 | This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Upsher-Smith Laboratories" – news ·newspapers ·books ·scholar ·JSTOR(September 2017) (Learn how and when to remove this message) |
 | |
| Company type | Subsidiary |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1919; 107 years ago (1919) inWayzata, Minnesota, U.S. |
| Headquarters | Maple Grove, Minnesota, U.S. |
Key people | |
| Products | |
| Parent |
|
| Website | www |
Upsher-Smith Laboratories, LLC is an American pharmaceutical company based inMaple Grove, Minnesota. Founded in 1919, it has been owned byBora Pharmaceuticals since 2024.
Founded in 1919 as a maker ofdigitalis drugs,[3] Upsher-Smith has traditionally focused on the manufacture of generic medications.
In 2017, after owning it for 47 years, the Evenstad family decided to sell most of the firm, the generics business, toSawai Group Holdings Co., Ltd. [jp], a large publicly traded generics company in Japan that had been seeking entry into the U.S. market.[4] Its non-generic pharmaceutical business, Proximagen, Pairnomix, and MOBĒ, remained with ACOVA, a holding company owned by the Evenstads.
On April 1, 2024, Upsher-Smith Laboratories was acquired by Bora Pharmaceuticals Co., Ltd., considered the largest pharmaceutical manufacturer inTaiwan.[5]
Upsher-Smith offers brand and generic pharmaceuticals to treat the following disease states:[7]
